A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer.

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...

COLUMBUS, Ohio (WCMH) – March is Colorectal Cancer Awareness Month, where health experts, patients and survivors are raising awareness and urging people to pay attention to their health. According to ...

USA: A new study from Memorial Sloan Kettering Cancer Center indicates that carefully selected patients with malignant colorectal polyps carrying high-risk features may be managed safely without ...

While there are several treatment options for colon cancer, not all of them work for all cancer types. Deficient mismatch repair (dMMR) colon cancer is known to be less responsive to chemotherapy than ...

If you're in your 40s, you might think colon cancer is something to worry about decades from now. But alarming new research ...

Here’s some food for thought: What’s on your plate could be putting you at risk for colorectal cancer. Once primarily associated with older adults, incidence of the disease has been steadily rising ...